Search Results for ""drugs for""
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for "drugs for". Results 2491 to 2500 of 2585 total matches.
Laser Treatment of Onychomycosis
The Medical Letter on Drugs and Therapeutics • Feb 18, 2013 (Issue 1410)
The Medical Letter®
On Drugs and Therapeutics
Volume 55 (Issue 1410)
February 18, 2013 ...
Fungal infections of the fingernails or toenails can persist
for months or years despite topical and systemic
antimicrobial therapy. The FDA has cleared several
short-pulse laser systems for treatment of this mainly
cosmetic disorder.
MiniMed 530G: An Insulin Pump with Low-Glucose Suspend Automation
The Medical Letter on Drugs and Therapeutics • Dec 09, 2013 (Issue 1431)
The Medical Letter®
On Drugs and Therapeutics
Volume 55 (Issue 1431)
December 9, 2013
Published ...
The FDA has approved the MiniMed 530G
(Medtronic), an insulin pump used in combination with
a continuous glucose monitoring sensor (Enlite) that
can stop delivery of insulin when interstitial glucose
reaches a prespecified low level. It is the only sensoraugmented
insulin pump available in the US with this
capability.
Low-Dose Aspirin for Prevention of Preeclampsia
The Medical Letter on Drugs and Therapeutics • Jun 23, 2014 (Issue 1445)
The Medical Letter®
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 145 ...
The American College of Obstetricians and Gynecologists
(ACOG) and the US Preventive Services Task
Force (USPSTF) have recommended that women at
risk for preeclampsia take low-dose aspirin daily after
the first trimester.
In Brief: Midostaurin (Rydapt) for AML and Advanced Systemic Mastocytosis (online only)
The Medical Letter on Drugs and Therapeutics • Aug 14, 2017 (Issue 1527)
with permission by First Databank, Inc. All rights reserved.
©2017. www.fdbhealth.com/policies/drug-pricing ...
The FDA has approved the oral multikinase inhibitor midostaurin (Rydapt – Novartis) for first-line treatment, in addition to standard chemotherapy, of adults with FLT3 (fms-like tyrosine kinase 3) mutation-positive acute myeloid leukemia (AML). About 30% of patients with AML have FLT3 mutations. Midostaurin is also approved as a single agent for treatment of adults with aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm, or mast-cell leukemia. In mastocytosis, midostaurin targets mutant c-KIT, not FLT3.In a randomized, double-blind trial, 717...
In Brief: Dapagliflozin (Farxiga) for Chronic Kidney Disease
The Medical Letter on Drugs and Therapeutics • Jul 26, 2021 (Issue 1629)
. All rights reserved. ©2021. www.fdbhealth.
com/policies/drug-pricing-policy. chronic kidney disease Forxiga ...
The sodium-glucose cotransporter 2 (SGLT2) inhibitor
dapagliflozin (Farxiga – AstraZeneca) has been
approved by the FDA for treatment of adults with
chronic kidney disease (CKD) at risk of progression
(not defined in the label). Dapagliflozin is the first
SGLT2 inhibitor to be approved in the US for treatment
of CKD.
Sunscreens
The Medical Letter on Drugs and Therapeutics • Jul 26, 2021 (Issue 1629)
. All rights reserved. ©2021. www.fdbhealth.
com/policies/drug-pricing-policy. sunscreens Insect repellents ...
Excessive exposure to ultraviolet (UV) radiation
is associated with sunburn, photoaging, and skin
cancer. Sunscreens are widely used to reduce these
risks, but questions remain about their effectiveness
and safety. The FDA has issued a proposed rule that
would require manufacturers to perform additional
safety studies for some sunscreen active ingredients
and would mandate better UVA protection in
sunscreen products. Some sunscreen products
containing FDA-approved active ingredients are
listed in Table 2.
In Brief: Doxycycline for STI Post-Exposure Prophylaxis
The Medical Letter on Drugs and Therapeutics • Jul 22, 2024 (Issue 1707)
of the drug could increase the incidence of nasal colonization with tetracycline-resistant Staphylococcus ...
The CDC has issued a recommendation for use
of a single dose of doxycycline for post-exposure
prophylaxis (PEP) of bacterial sexually transmitted
infections (STIs), specifically syphilis, chlamydia, and
gonorrhea, in men who have sex with men (MSM) and
transgender women (TGW) who had a bacterial STI
within the previous 12 months.
Med Lett Drugs Ther. 2024 Jul 22;66(1707):119-20 doi:10.58347/tml.2024.1707f | Show Introduction Hide Introduction
Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Chronic Weight Management (online only)
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024 (Issue 1708)
pancreatitis and acute gall bladder disease
Drug Eligible Patients Usual Dosage Other Information
GLP-1 ...
View the Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Chronic Weight Management
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-2 doi:10.58347/tml.2024.1708d | Show Introduction Hide Introduction
Dexamethasone Bacterial Meningitis In Children
The Medical Letter on Drugs and Therapeutics • Jan 27, 1989 (Issue 784)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
A recent report in the New England Journal of Medicine suggested that in children with bacterial meningitis, adding the corticosteroid dexamethasone (Decadron; and others) to antibiotic treatment could decrease the incidence of moderate or severe hearing loss.
Balloon Dilatation Of The Prostate
The Medical Letter on Drugs and Therapeutics • Jun 29, 1990 (Issue 821)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
To avoid the morbidity and occasional mortality of transurethral resection or open prostatectomy, some urologists are now using balloon dilatation of the prostatic urethra to treat benign prostatic hypertrophy.